VYTRUS BIOTECH EO -01 (V5P) — Cash Flow Quality Index
VYTRUS BIOTECH EO -01 (V5P) has a Cash Flow Quality Index of 1.35x as of December 2025. Operating cash flow of €3.90 Million exceeds net income of €2.90 Million, indicating high earnings quality where cash backs reported profits. Also explore V5P total assets for the complete picture of this company's asset base.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
VYTRUS BIOTECH EO -01 Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for VYTRUS BIOTECH EO -01 across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check V5P intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for VYTRUS BIOTECH EO -01 (2021–2025)
Year-by-year earnings quality comparison for VYTRUS BIOTECH EO -01. For live market cap and the full company financial profile, see V5P market cap.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.35x | €3.90 Million | €2.90 Million | ▼ -25.4% |
| 2024 | 1.81x | €1.84 Million | €1.02 Million | ▲ +8.8% |
| 2023 | 1.66x | €904.39K | €544.94K | ▼ -2.1% |
| 2022 | 1.70x | €1.03 Million | €605.26K | ▲ +70.3% |
| 2021 | 1.00x | €447.92K | €450.02K | — |